Advertisement
Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates
(RTTNews) - Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.
Total revenues for the quarter soared to $12.39 million from $0.01 million in the same quarter last year, primarily due to SKYSONA and ZYNTEGLO product revenue. On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.67 per share on revenues of $13.41 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
hace 799
U.S. GDP Jumps More Than Previously Estimated In Q2
The U.S. economy grew by more than previously estimated in the second quarter of 2025, according to revised data released by the Commerce Department on Thursday.
RTTNews
|
hace 5 minutos
U.S. Weekly Jobless Claims Edge Down To 229,000
A report released by the Labor Department on Thursday showed a modest decrease by first-time claims for U.S. unemployment benefits in the week ended August 23rd.
RTTNews
|
hace 10 minutos
FTSE 100 Down 0.4% In Cautious Trade
After a slightly positive start, U.K. stocks turned weak Thursday morning with investors treading cautiously amid a lack of triggers. Shares of financials and utilities companies are struggling a bit.
RTTNews
|
hace 1h 21min
CAC Up Slightly; Pernod Ricard Rises On Earnings
The French market is up slightly a little past noon on Thursday, supported by data showing an increase in new car registrations in Europe, and stronger-than-expected results and forecast from AI chip major Nvidia.
RTTNews
|
hace 1h 39min
DAX Retreats After Firm Start, Down Marginally
After opening on a strong note thanks to easing AI slowdown fears after Nvidia's impressive results, the German market retreated and slipped into negative territory on Thursday. Despite paring some early gains, auto stocks remain fairly well up in positive territory.
RTTNews
|
hace 2h 3min
Swiss Franc Rises Against Majors
The Swiss franc strengthened against other major currencies in the European session on Thursday.
RTTNews
|
hace 2h 18min
Sensex, Nifty Retreat On US Tariff Worries
Indian shares fell sharply on Thursday as traders waited to see how New Delhi responds to pressure from Washington to stop buying Russian oil after the 50 percent tariffs levied by the U.S. on Indian goods came into effect on Wednesday.
RTTNews
|
hace 2h 24min
